Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The MEND Pilot Feasibility Study
NCT07222072Phase 4Recruiting
- Sponsor
- Cleveland Clinic
- Start
- Nov 2025
- Primary completion
- Oct 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in postoperative pain comparing Methadone Group with Placebo Group (2 arms). Primary endpoints: Feasibility and Acceptability-Participant Willingness/Recruitment at 7 days, Feasibility and Acceptability-Provider Engagement at 7 days and 3 more. Started Nov 2025; status: recruiting.
02
Drugs
methadone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07222072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07222072.